Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

44.04
Delayed Data
As of Jul 25
 +0.16 / +0.36%
Today’s Change
36.71
Today|||52-Week Range
44.85
+10.71%
Year-to-Date
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Huge Drugmaker Fines for Bribing Healthcare Providers
Jul 22 / MotleyFool.com - Paid Partner Content
Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
3 Hold-Rated Dividend Stocks: DRH, GSK, DBD
Jul 20 / TheStreet.com - Paid Partner Content
Global Week Ahead: Report Card Time for European Banks, BOJ Monetary Policy Meeting
Jul 24 / TheStreet.com - Paid Partner Content
Why Berkshire Hathaway Dumped Johnson & Johnson
Jul 19 / GuruFocus News - Paid Partner Content
GlaxoSmithKline's Sideways Dance May Pay Off in the Long Run
Jul 22 / GuruFocus News - Paid Partner Content
How Do Healthcare Companies Market Their Products?
Jul 19 / MotleyFool.com - Paid Partner Content
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
Novartis Second-Quarter Earnings, Revenue Fall Less Than Forecast
Jul 19 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close43.88
Today’s open43.93
Day’s range43.65 - 44.06
Volume2,057,560
Average volume (3 months)3,449,264
Market cap$106.9B
Dividend yield5.18%
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+12.43%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.66%
P/E ratio188.2
Price/Sales2.70
Price/Book14.09

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.33-0.59%
SNYSanofi-0.17-0.40%
ABBVAbbVie+0.51+0.80%
AGNAllergan-1.13-0.45%
Data as of 07/25/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs